Tandem Diabetes Care Inc (TNDM)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -91,870 | -220,254 | -92,852 | 15,901 | -36,282 |
| Revenue | US$ in thousands | 940,203 | 747,718 | 801,217 | 702,799 | 498,830 |
| Pretax margin | -9.77% | -29.46% | -11.59% | 2.26% | -7.27% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $-91,870K ÷ $940,203K
= -9.77%
The pretax margin of Tandem Diabetes Care Inc has shown fluctuations over the past five years, ranging from a low of -29.46% on December 31, 2023, to a high of 2.26% on December 31, 2021. The company experienced a negative pretax margin in three out of the five years analyzed, indicating that its operating profits before taxes were insufficient to cover operating expenses and other costs. The most significant decline in pretax margin occurred in 2023, dropping sharply to -29.46%. This could suggest challenges in managing costs or generating sufficient revenue during that year. Overall, Tandem Diabetes Care Inc has struggled to maintain a consistently positive pretax margin, highlighting the need for improved operational efficiency and financial performance in the future.
Peer comparison
Dec 31, 2024